These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 16972946)

  • 41. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome.
    D'Incan M; Souteyrand P; Bignon YJ; Fonck Y; Roger H
    Arch Dermatol; 1992 Oct; 128(10):1371-4. PubMed ID: 1417026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome.
    Shono Y; Suga H; Kamijo H; Fujii H; Oka T; Miyagaki T; Shishido-Takahashi N; Sugaya M; Sato S
    Acta Derm Venereol; 2019 Jul; 99(9):809-812. PubMed ID: 31045236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome).
    Galindo LM; Garcia FU; Hanau CA; Lessin SR; Jhala N; Bigler RD; Vonderheid EC
    Am J Clin Pathol; 2000 Jun; 113(6):865-71. PubMed ID: 10874888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
    Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic tools in Sezary syndrome.
    Möbs M; Knott M; Fritzen B; Pullmann S; Sterry W; Assaf C
    G Ital Dermatol Venereol; 2010 Jun; 145(3):385-91. PubMed ID: 20461046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of treatments for mycosis fungoides and Sézary syndrome: nationwide survey responses.
    Gettler SL; Fung MA
    Dermatol Online J; 2005 Dec; 11(3):6. PubMed ID: 16409902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epidermotropic T lymphomas].
    Sigal-Nahum M; Brousse N; Belaïch S
    Rev Prat; 1987 May; 37(25):1423-31. PubMed ID: 3495856
    [No Abstract]   [Full Text] [Related]  

  • 51. Ultrastructural morphometry in the diagnosis of mycosis fungoides and Sézary's syndrome.
    Payne CM
    Clin Dermatol; 1991; 9(2):187-203. PubMed ID: 1747854
    [No Abstract]   [Full Text] [Related]  

  • 52. Cutaneous T cell lymphoma differing from classical mycosis fungoides and Sézary syndrome: clinical, histological and immunohistochemical studies of six cases.
    Maeda K; Takahashi M; Takatsuka N; Miyazawa H
    J Dermatol; 1990 Apr; 17(4):226-34. PubMed ID: 2195088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mycosis fungoides: a dermatological masquerader.
    Nashan D; Faulhaber D; Ständer S; Luger TA; Stadler R
    Br J Dermatol; 2007 Jan; 156(1):1-10. PubMed ID: 17199560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Juvenile folliculotropic and ichthyosiform mycosis fungoides.
    Ryan C; Whittaker S; D'Arcy C; O'Regan GM; Rogers S
    Clin Exp Dermatol; 2009 Jul; 34(5):e160-2. PubMed ID: 19094122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Scleromyxedematous Changes in a Patient With Long-Standing Mycosis Fungoides Who Progressed to Sézary Syndrome.
    Miraflor AP; Pulitzer MP; Myskowski PL; Geller S
    Am J Dermatopathol; 2019 Nov; 41(11):e139-e143. PubMed ID: 31169525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A histo-immunopathologic and prognostic study of erythrodermic cutaneous T-cell lymphoma.
    Vonderheid EC; Kantor GR; Telang GH; Bujanouskas P; Kadin ME
    J Cutan Pathol; 2019 Dec; 46(12):913-924. PubMed ID: 31403211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human T-cell leukemia virus in cutaneous T-cell lymphoma in Denmark. A possible association of HTLV and aneuploidy.
    Lange Wantzin G; Saxinger WC; Woods A; Larsen JK; Thomsen K; Gallo RC
    Acta Derm Venereol; 1984; 64(5):395-9. PubMed ID: 6208717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mycosis fungoides and the Sézary syndrome.
    Kim YH; Hoppe RT
    Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells.
    Lyapichev KA; Bah I; Huen A; Duvic M; Routbort MJ; Wang W; Jorgensen JL; Medeiros LJ; Vega F; Craig FE; Wang SA
    Cytometry B Clin Cytom; 2021 Mar; 100(2):183-191. PubMed ID: 32667737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidermal Langerhans cells and prognosis of patients with mycosis fungoides and Sezary syndrome.
    Meissner K; Löning T; Rehpenning W
    In Vivo; 1993; 7(3):277-80. PubMed ID: 8357970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.